« Previous
Next »
Titles
- Behavioral health and COVID-19: higher-risk populations and related federal relief funding : report to congressional committees1
- Behavioral health: Available workforce information and federal actions to help recruit and retain providers : report to congressional requesters1
- Benefit-risk assessment for new drug and biological products: guidance for industry1
- Best practices for convening a GRAS panel: guidance for industry1
- Billions in estimated Medicare Advantage payments from diagnoses reported only on health risk assessments raise concerns1
- Biomedical research: information on federal contributions to remdesivir : report to Congressional addressees1
- Black Lung Benefits Program: oversight is needed to address trust fund solvency strained by bankruptcies : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives1
- Black Lung benefits program: continued inaction on coal operator self-insurance increases financial risk to trust fund : testimony before the Committee on Education and Labor, Subcommittee on Workforce Protections, House of Representatives1
- Breakthrough Devices Program: guidance for industry and Food and Drug Administration staff1
- Bridging the gaps: state and local strategies for ensuring backup personal care services1
- Bureau of Prisons: assessment of health care reentry policies and procedures needed : report to congressional committees1